Source: iQoncept / Shutterstock
Mira Pharmaceuticals (NASDAQ:MIRA) just reported results for the first quarter of 2024.
- Mira Pharmaceuticals reported earnings per share of -12 cents. This was below the analyst estimate for EPS of -10 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/mira-stock-earnings-mira-pharmaceuticals-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC